DOCSLIB.ORG

Subxiphoid Video-Assisted Thoracic Surgery

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subxiphoid Video-Assisted Thoracic Surgery AME Surgery Series 6A007 6A007 Thoracic Surgery Thoracic Video- Subxiphoid Subxiphoid Video-Assisted Thoracic Surgery Editors: Lei Jiang Giuseppe Aresu Associate Editors: Diego Gonzalez-Rivas www.amegroups.com Alan D. L. Sihoe A Gaetano Rocco ssisted ssisted Jason M. Ali Gening Jiang Editors: Giuseppe Aresu Giuseppe Lei Jiang AME Surgery Series 6A007 Subxiphoid Video-Assisted Thoracic Surgery Editors: Lei Jiang Giuseppe Aresu Associate Editors: Diego Gonzalez-Rivas Alan D. L. Sihoe Gaetano Rocco Jason M. Ali Gening Jiang AME Publishing Company Room C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong Information on this title: www.amegroups.com For more information, contact [email protected] Copyright © AME Publishing Company. All rights reserved. This publication is in copyright. Subject to statutory exception and to the provisions of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of AME Publishing Company. First published in 2018 Printed in China by AME Publishing Company Editors: Lei Jiang, Giuseppe Aresu Cover Image Illustrator: Anthony P. Yim, HongKong, China Subxiphoid Video-Assisted Thoracic Surgery (Hard Cover) ISBN: 978-988-79496-1-9 AME Publishing Company, Hong Kong AME Publishing Company has no responsibility for the persistence or accuracy of URLs for external or third-party internet websites referred to in this publication, and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. The advice and opinions expressed in this book are solely those of the authors and do not necessarily represent the views or practices of the publisher. No representation is made by the publisher about the suitability of the information contained in this book, and there is no consent, endorsement or recommendation provided by the publisher, express or implied, with regard to its contents. I SUBXIPHOID VIDEO-ASSISTED THORACIC SURGERY (FIRST EDITION) EDITORS CONTRIBUTORS Lei Jiang Amr Abdellateef Department of Thoracic Surgery, Shanghai Pulmonary Department of Thoracic Surgery, Shanghai Pulmonary Hospital affiliated to Tongji University School of Medicine, Hospital, Tongji University, Shanghai 200433, China Shanghai 200433, China Firas Abu Akar Giuseppe Aresu Department of Thoracic Surgery, Shanghai Pulmonary Department of Cardiothoracic Surgery, Papworth Hospital, Hospital, Tongji University School of Medicine, Shanghai Cambridgeshire, UK 200433, China Jason M. Ali ASSOCIATE EDITORS Thoracic Surgery, Royal Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge, UK Diego Gonzalez-Rivas Department of Thoracic Surgery, Shanghai Pulmonary Giuseppe Aresu Hospital, Tongji University School of Medicine, Shanghai Thoracic Surgery, Royal Papworth Hospital NHS 200433, China; Department of Thoracic Surgery, Coruña Foundation Trust, Papworth Everard, Cambridge, UK University Hospital and Minimally Invasive Thoracic Surgery Unit (UCTMI), Coruña, Spain Zhigang Chen Department of Thoracic Surgery and Anaesthesia, Shanghai Alan D. L. Sihoe Pulmonary Hospital, Tongji University, Shanghai 200433, China Department of Surgery, The University of Hong Kong, Hong Kong, China; Department of Surgery, The University of Jian Chen Hong Kong Shenzhen Hospital, Shenzhen 518053, China; Department of Thoracic Surgery, Shanghai Pulmonary Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai Hospital, Tongji University, Shanghai 200433, China 200433, China Gaetano Rocco Chih-Tao Cheng Department of Surgery, Memorial Sloan Kettering Cancer Department of Medical Research, Koo Foundation Sun Center, 1275 York Avenue, New York, NY, USA Yat-Sen Cancer Center, Taipei, Taiwan, China Jason M. Ali Serena Concina Thoracic Surgery, Royal Papworth Hospital NHS Foundation Department of General Surgery, Santa Maria della Trust, Papworth Everard, Cambridge, UK Misericordia University Hospital, Udine, Italy Gening Jiang Aman Coonar Department of Thoracic Surgery, Shanghai Pulmonary Department of Thoracic Surgery, Papworth Hospital NHS Hospital, Tongji University, Shanghai 200433, China Foundation Trust, Cambridge, UK © AME Publishing Company. All rights reserved. www.amegroups.com II Wojciech Czajkowski Mahmoud Ismail Department of Thoracic Surgery, Pulmonary Hospital, Department of Thoracic Surgery, Erns Von Bergmann Zakopane, Poland hospital, Potsdam, Germany Joel Dunning Shruti Jayakumar Department of Cardiothoracic Surgery, James Cook Department of General Surgery, Santa Maria della University Hospital, Middlesbrough, UK Misericordia University Hospital, Udine, Italy Haiyang Fan Lei Jiang Department of Thoracic Surgery, The Seventh Hospital, Department of Thoracic Surgery, Shanghai Pulmonary Sun Yat-sen University, Shenzhen City, Guangdong Hospital affiliated to Tongji University School of Medicine, Province 518107, China Shanghai 200433, China Mario Ferrante Gening Jiang Department of Anaesthesia, Royal Papworth Hospital, Department of Thoracic Surgery, Shanghai Pulmonary Cambridge, UK Hospital, Tongji University, Shanghai 200433, China Matthew Fok Jay Karunanantham Department of Thoracic Surgery, Papworth Hospital NHS Department of Thoracic Surgery, Papworth Hospital NHS Foundation Trust, Cambridge, UK Foundation Trust, Cambridge, UK Edward Fryzlewicz Pradeep Kaul Department of Anaesthesiology and Intensive Care, Thoracic Surgery, Papworth Hospital NHS Foundation Pulmonary Hospital, Zakopane, Poland Trust, Papworth Everard, Cambridge, UK Diego Gonzalez-Rivas Sylweriusz Kosinski Department of Thoracic Surgery, Coruña University Department of Anaesthesiology and Intensive Care, Hospital and Minimally Invasive Thoracic Surgery Unit Pulmonary Hospital, Zakopane, Poland (UCTMI), Coruña, Spain; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University Lei Lin School of Medicine, Shanghai 200433, China Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, China William Guido Guerrero Department of Thoracic Surgery, Shanghai Pulmonary Francisco Lirio Hospital, Tongji University School of Medicine, Shanghai Department of Thoracic Surgery, Hospital General 200433, China; Department of Thoracic Surgery, Rafael Universitario Alicante, Alicante, Spain Angel Calderón Guardia Hospital, San José, Costa Rica Chia-Chuan Liu Luis Angel Hernandez-Arenas Division of Thoracic Surgery, Department of Surgery, Koo Department of Thoracic Surgery, Shanghai Pulmonary Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, Hospital affiliated to Tongji University School of Medicine, China Shanghai 200433, China Yun-Hen Liu Jing Huang Division of Thoracic Surgery, Chang Gung Memorial Department of Respiration, Shanghai Pulmonary Hospital, Hospital, College of Medicine, Chang Gung University, Tongji University School of Medicine, Shanghai 200433, Keelung, Taiwan, China China © AME Publishing Company. All rights reserved. www.amegroups.com III Zhen-Ying Liu Alan D. L. Sihoe Department of Medical Research, Koo Foundation Sun Department of Surgery, The University of Hong Kong, Yat-Sen Cancer Center, Taipei, Taiwan, China Hong Kong, China; Department of Surgery, The University of Hong Kong Shenzhen Hospital, Shenzhen 518053, China; Enrico Melis Department of Thoracic Surgery, Shanghai Pulmonary Division of Thoracic Surgery, Department of Surgical Hospital, Tongji University, Shanghai 200433, China Oncology, Regina Elena National Cancer Institute, Rome, Italy Katarzyna Solarczyk-Bombik Jacobo Moreno Garijo Department of Thoracic Surgery, Pulmonary Hospital, Department of Anesthesia & Pain Management, Toronto Zakopane, Poland General Hospital, Toronto, Canada Sandro Sponga Tomasz Nabialek Department of Thoracic Surgery, Santa Maria della Department of Anaesthesiology and Intensive Care, Misericordia University Hospital, Udine 33100, Italy Pulmonary Hospital, Zakopane, Poland Takashi Suda Juliusz Pankowski Division of Thoracic Surgery, Fujita Health University Department of Pathology, Pulmonary Hospital, Zakopane, School of Medicine, Toyoake, Aichi, Japan Poland Malgorzata Szolkowska Chinmay Patvardhan Department of Pathology of the Tuberculosis Institute, Department of Anaesthesia, Royal Papworth Hospital, Warsaw, Poland Cambridge, UK Sara Volpi Adam Peryt Thoracic Surgery, Royal Papworth Hospital NHS Department of Thoracic Surgery, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge, UK Foundation Trust, Cambridge, UK Helen Weaver Jichen Qu Department of Cardiothoracic Surgery, Papworth Hospital, Department of Thoracic Surgery, Shanghai Pulmonary Cambridgeshire, UK Hospital, Tongji University School of Medicine, Shanghai 200433, China Michal Wilkojc Department of Thoracic Surgery, Pulmonary Hospital, Andrew Roscoe Zakopane, Poland Department of Anaesthesia, Royal Papworth Hospital, Cambridge, UK Liang Wu Department of Thoracic Surgery, Shanghai Pulmonary Mariusz Rybak Hospital, Tongji University, Shanghai 200433, China Department of Thoracic Surgery, Pulmonary Hospital, Zakopane, Poland Huan Xu Department of Thoracic Surgery and Anaesthesia, Shanghai Julio Sesma Pulmonary Hospital, Tongji University, Shanghai 200433, Department of Thoracic Surgery, Hospital General China Universitario Alicante, Alicante, Spain Chenlu Yang Chih-Shiun Shih Department of Thoracic Surgery, Shanghai Pulmonary Division of Thoracic Surgery, Department of Surgery, Koo Hospital, Tongji University School of Medicine, Shanghai Foundation Sun Yat-Sen Cancer Center,
Load more

Recommended publications
  • Pericardiocentesis Versus Pericardiotomy for Malignant Pericardial Effusion: a Retrospective Comparison
    MALIGNANT PERICARDIAL EFFUSION, Labbé et al. ORIGINAL ARTICLE Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: a retrospective comparison C. Labbé MD,* L. Tremblay MD,* and Y. Lacasse MD MSc* ABSTRACT Background Treatment of malignant pericardial effusion remains controversial, because no randomized controlled trials have been conducted to determine the best approach, and results of retrospective studies have been inconsistent. The objective of the present study was to compare pericardiocentesis and pericardiotomy with respect to efficacy for preventing recurrence, and to determine, for those two procedures, diagnostic yields, complication rates, and effects on survival. We also aimed to identify clinical and procedural factors that could predict effusion recurrence. Methods We retrospectively assessed 61 patients who underwent a procedure for treatment of a malignant pericardial effusion at the Institut universitaire de cardiologie et de pneumologie de Québec between February 2004 and September 2013. Results Pericardiocentesis was performed in 42 patients, and pericardiotomy, in 19 patients. The effusion recurrence rate was significantly higher in patients treated with pericardiocentesis than with pericardiotomy (31.0% vs. 5.3%, p = 0.046). The diagnostic yield of the procedures was not significantly different (92.9% vs. 86.7%, p = 0.6). The overall rate of complications was similar in the two groups, as was the median overall survival (2.4 months vs. 2.6 months, p = 0.5). In univariate analyses, the procedure type was the only predictor of recurrence that approached statistical significance. Age, sex, type of cancer, presence of effusion at the time of cancer diagnosis, prior chest irradiation, tamponade upon presentation, and total volume of fluid removed did not influence the recurrence rate.
    [Show full text]
  • Pericardial Injury with Cardiac Tamponade from Multiple Stab Injuries of the Trunk: Incidental Release of Cardiac Tamponade
    eISSN: 2508-8033 Treatment Progression in Trauma pISSN: 2508-5298 Pericardial Injury With Cardiac Tamponade From Multiple Stab Injuries of the Trunk: Incidental Release of Cardiac Tamponade Pil Young Jung1, Kwan Wook Kim2 1Department of Surgery, Yonsei university Wonju college of medicine, Wonju Severance Christian Hospital 2Trauma center, Department of Thoracic and Cardiovascular Surgery, CHA University, CHA Bundang Medical Center Traumatic hemopericardium with cardiac tamponade is a rare but life-threatening condition. We report the successful treatment of hemopericardium with cardiac tamponade caused by multiple stab injuries of the trunk. (Trauma Image Proced 2019(1):22-24) Key Words: Hemopericardium, Cardiac tamponade CASE tion of the left internal mammary vessels, which was the cause of hemopericardium (Fig. 3.). The epicardium of From a regional local hospital, a 34-year-old man the right ventricle, the greater omentum, and the spleen who had schizophrenia was transferred to our institution were injured; the diaphragmatic injury may have served with multiple stab injuries of the trunk, sustained in a as a pericardial window of injury into the abdomen suicide attempt (Fig. 1.). At admission, the patient’s vital cavity. We performed ligation of the left internal signs were unstable; cardiac arrest occurred, and return mammary vessels, splenectomy, omentectomy, and of spontaneous circulation was achieved after one cycle primary repair of the diaphragm. The patient recovered of cardiopulmonary resuscitation. The extended focused and was discharged without any complication 24 days assessment sonography in trauma revealed positive signs after admission (Fig. 4.). in the pericardium and splenorenal space. Computed tomographic scans taken at the previous hospital showed DISCUSSION hemopericardium and hemoperitoneum (Fig.
    [Show full text]
  • Appendix A: Surgical Procedure Terms and Definitions
    Appendix A: Surgical Procedure Terms and Definitions Anomalous Systemic Venous Connection Anomalous Systemic Venous Connection Repair Repair includes a range of surgical approaches, including, among others: ligation of anomalous vessels, reimplantation of anomalous vessels (with or without use of a conduit), or redirection of anomalous systemic venous flow through directly to the pulmonary circulation (bidirectional Glenn to redirect LSVC or RSVC to left or right pulmonary artery, respectively). Aortic Aneurysm Aortic aneurysm repair Aortic aneurysm repair by any technique. Aortic Dissection Aortic Dissection repair Aortic dissection repair by any technique. Aortic Root Replacement Aortic Root Replacement, Bioprosthetic Replacement of the aortic root (that portion of the aorta attached to the heart; it gives rise to the coronary arteries) with a bioprosthesis (e.g., porcine) in a conduit, often composite. Aortic Root Replacement, Mechanical Replacement of the aortic root (that portion of the aorta attached to the heart; it gives rise to the coronary arteries) with a mechanical prosthesis in a composite conduit. Aortic Root Replacement, Homograft Replacement of the aortic root (that portion of the aorta attached to the heart; it gives rise to the coronary arteries) with a homograft Aortic Root Replacement, Valve sparing Replacement of the aortic root (that portion of the aorta attached to the heart; it gives rise to the coronary arteries) without replacing the aortic valve (using a tube graft). Aortic Valve Disease Ross Procedure Replacement of the aortic valve with a pulmonary autograft and replacement of the pulmonary valve with a homograft conduit. Konno Procedure (with and without aortic valve replacement) Relief of left ventricular outflow tract obstruction associated with aortic annular hypoplasia, aortic valvar stenosis and/or aortic valvar insufficiency via Konno aortoventriculoplasty.
    [Show full text]
  • ICD-9-CM Procedures (FY10)
    2 PREFACE This sixth edition of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is being published by the United States Government in recognition of its responsibility to promulgate this classification throughout the United States for morbidity coding. The International Classification of Diseases, 9th Revision, published by the World Health Organization (WHO) is the foundation of the ICD-9-CM and continues to be the classification employed in cause-of-death coding in the United States. The ICD-9-CM is completely comparable with the ICD-9. The WHO Collaborating Center for Classification of Diseases in North America serves as liaison between the international obligations for comparable classifications and the national health data needs of the United States. The ICD-9-CM is recommended for use in all clinical settings but is required for reporting diagnoses and diseases to all U.S. Public Health Service and the Centers for Medicare & Medicaid Services (formerly the Health Care Financing Administration) programs. Guidance in the use of this classification can be found in the section "Guidance in the Use of ICD-9-CM." ICD-9-CM extensions, interpretations, modifications, addenda, or errata other than those approved by the U.S. Public Health Service and the Centers for Medicare & Medicaid Services are not to be considered official and should not be utilized. Continuous maintenance of the ICD-9- CM is the responsibility of the Federal Government. However, because the ICD-9-CM represents the best in contemporary thinking of clinicians, nosologists, epidemiologists, and statisticians from both public and private sectors, no future modifications will be considered without extensive advice from the appropriate representatives of all major users.
    [Show full text]
  • ICD-9-CM Coordination and Maintenance Committee Meeting September 28-29, 2006 Diagnosis Agenda
    ICD-9-CM Coordination and Maintenance Committee Meeting September 28-29, 2006 Diagnosis Agenda Welcome and announcements Donna Pickett, MPH, RHIA Co-Chair, ICD-9-CM Coordination and Maintenance Committee ICD-9-CM TIMELINE .................................................................................................... 2 Hearing loss, speech, language, and swallowing disorders ........................................... 8 Kyle C. Dennis, Ph.D., CCC-A, FAAA and Dee Adams Nikjeh,Ph.D., CCC-SLP American Speech-Language-Hearing Association Urinary risks factors for bladder cancer ...................................................................... 13 Louis S. Liou, M.D., Ph.D., Abbott Chronic Total Occlusion of Artery of Extremities....................................................... 15 Matt Selmon, M.D., Cordis Osteonecrosis of jaw ....................................................................................................... 17 Vincent DiFabio,M.D., American Association of Oral and Maxillofacial Surgeons Intraoperative Floppy Iris Syndrome ........................................................................... 18 Priscilla Arnold, M.D., American Society of Cataract and Refractive Surgery Septic embolism............................................................................................................... 19 Parvovirus B19 ................................................................................................................ 21 Avian Influenza (Bird Flu)............................................................................................
    [Show full text]
  • Instructions and Data Element Definitions Form DOH-2254A
    NEW YORK STATE DEPARTMENT OF HEALTH DIVISION OF QUALITY AND PATIENT SAFETY CARDIAC SERVICES PROGRAM 2014 Discharges Cardiac Surgery Report, Adult (Age 18 and Over) Instructions and Data Element Definitions Form DOH-2254a CARDIAC SERVICES PROGRAM CONTACTS: One University Place, Suite 218 Rensselaer, NY 12144-3455 Phone: (518) 402-1016 Fax: (518) 402-6992 Kimberly S. Cozzens, MA, Cardiac Initiatives Research Manager, [email protected] Rosemary Lombardo, MS, CSRS Coordinator, [email protected] Table of Contents Topic Page Revision Highlights and Coding Clarifications…………………..…………… 6 When to Complete an Adult CSRS Form ……………………………………. 6 Guidance on Selecting Appropriate Procedure Codes ………………….... 8 CSRS Data Reporting Policies ……………………………………….………. 10 ITEM-BY-ITEM INSTRUCTIONS PFI Number ………………………………………………………………... 12 Sequence Number ………………………………………………………... 12 I. Patient Information Patient Name ……………………………………………………………… 12 Medical Record Number …………………………………………………. 12 Social Security Number ………………………………………………….. 12 Date of Birth ………………………….………………………….………… 12 Sex ………………………….………………………….…………………… 13 Ethnicity ………………………….………………………….……………... 13 Race ………………………….…………………………………………….. 13 Residence Code ………………………….……………………………….. 14 Hospital Admission Date ………………………….……………………… 14 Primary Payer ………………………….………………………………….. 14 Medicaid ………………………….………………………….…………….. 15 PFI of Transferring Hospital ………………………….………………….. 15 II. Procedural Information Hospital That Performed Diagnostic Cath ………………………….…… 16 Date of Surgery ………………………….…………………………………
    [Show full text]
  • NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Pediatric Cardiac Surgery Measures
    NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Pediatric Cardiac Surgery Measures Measure Number: PCS‐001‐09 Measure Title: Participation in a national database for pediatric and congenital heart surgery Description: Participation in at least one multi‐center, standardized data collection and feedback program that provides benchmarking of the physician’s data relative to national and regional programs and uses process and outcome measures. Participation is defined as submission of all congenital and pediatric operations performed to the database. Numerator Statement: Whether or not there is participation in at least one multi‐center data collection and feedback program. Denominator Statement: N/A Level of Analysis: Group of clinicians, Facility, Integrated delivery system, health plan, community/population Data Source: Electronic Health/Medical Record, Electronic Clinical Database (The Society of Thoracic Surgeons Congenital Heart Surgery Database), Electronic Clinical Registry (The Society of Thoracic Surgeons Congenital Heart Surgery Database), Electronic Claims, Paper Medical Record Measure Developer: Society of Thoracic Surgeons Type of Endorsement: Recommended for Time‐Limited Endorsement (Steering Committee Vote, Yes‐9, No‐0, Abstain‐0) Attachments: “STS Attachment: STS Procedure Code Definitions” Meas# / Title/ Steering Committee Evaluation and Recommendation (Owner) PCS-001-09 Recommendation: Time-Limited Endorsement Yes-9; No-0; Abstain-0 Participatio n in a Final Measure Evaluation Ratings: I: Y-9; N-0 S: H-4; M-4; L-1 U: H-9; M-0; L-0 national F: H-7; M-2; L-0 database for Discussion: pediatric I: The Steering Committee agreed that this measure is important to measure and report. and By reporting through a database, it is possible to identify potential quality issues and congenital provide benchmarks.
    [Show full text]
  • Emergency Open Cardiac Massage Via Subxyphoid Approach in Ruptured Type a Aortic Dissection
    SIGNA VITAE 2010; 5(2): 32 -34 CASE REPORT CHAO-WEN CHEN ( ) Department of Trauma Emergency Open Cardiac Kaohsiung Medical University Hospital 100 Tzyou 1st Road Kaohsiung 807, Taiwan Phone: +88673125895 ext 7553 Massage via Subxyphoid Fax: +88673208255 Approach in Ruptured Type E-mail: [email protected] HSING-LIN LIN • WEI-CHE LEE • SHING-GHI LIN • LIANG-CHI KUO • A Aortic Dissection YUAN-CHIA CHENG Department of Trauma Kaohsiung Medical University Hospital HSING-LIN LIN • WEI-CHE LEE • SHING-GHI LIN • LIANG-CHI KUO • Kaohsiung Medical University YUAN-CHIA CHENG • CHAO-WEN CHEN Kaohsiung, Taiwan HSING-LIN LIN • WEI-CHE LEE KUO • YUAN-CHIA CHENG Department of emergency Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung, Taiwan HSING-LIN LIN Division of General Surgery Department of Surgery Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung, Taiwan HSING-LIN LIN MD Graduate Institute of Healthcare Administration Kaohsiung Medical University Kaohsiung, Taiwan ABSTRACT Patient sustained cardiac tamponade caused by rupture of type A aortic dissection may result in sudden death. Pericardio- centesis is a lifesaving procedure; nevertheless, blood may occlude the catheter and fail to relieve the pressure. However, open-chest cardiac massage in resuscitation has been studied in animal models by some medical centers and laboratories with inspiring results. We report a 58-year-old woman who was transferred from a local hospital with the diagnosis of cardiac tamponade caused by ruptured type A aortic dissection. Pulseless electrical activity followed by cardiac arrest occurred thereafter. Successful resuscitation in the emergency department was achieved using open cardiac massage through the sub-xyphoid region by opening a pericardial window.
    [Show full text]
  • The 2012 Coding Manual Collection
    The 2012 Coding Manual Collection SaMple pageS ICD-9-CM Manual, Volumes 1, 2 & 3 (Hospital Edition) ICD-9-CM Manual, Volume 1 & 2 (Professional Edition) HCPCS Level II Manual The following 10 sample pages are from HCpro’s 2011 ICD-9-CM Coding Manual, Volumes 1, 2 & 3 SaMple pageS ICD-9-CM Manual, Volumes 1, 2 & 3 (Hospital Edition) 2011 ICD-9-CM Conventions HCPro’s ICD-9-CM manuals include all the symbols and conventions Please note: Certain categories of codes only consider a particular set of found in the government’s official version (see Preface and ICD-9-CM fifth digits to be a CC condition. Official Guidelines for Coding and Reporting). In addition, HCPro’s ICD- • For example: 9-CM manuals include the following icons and color-coded conventions: Category 403.9x. CC 1 ✓4 TH Fourth digit required. In order to accurately assign a diagnosis This means that ICD-9 code 403.90 is not considered a CC condition, but from this category, it requires the assignment of a fourth digit. 403.91 is designated as a CC condition. • For example: Category 465.x requires a fourth digit of a 0, 8, or 9 to be assigned an accurate code. MCC Major Complication and Comorbidity. This diagnosis is considered a major complication and/comorbidity. Assignment of these ✓5 TH Fifth digit required. In order to accurately assign a diagnosis from diagnoses as an additional code may impact DRG assignment. this category, it requires the assignment of a fifth digit. • For example: 585.6 (End stage renal disease) is • For example: Category 642.0x requires a fifth digit of a 0, 1, 2, 3, or designated as an MCC.
    [Show full text]
  • Contemporary Outcomes After Pericardial Window Surgery: Impact of Operative Technique Sarah E
    Langdon et al. Journal of Cardiothoracic Surgery (2016) 11:73 DOI 10.1186/s13019-016-0466-3 RESEARCH ARTICLE Open Access Contemporary outcomes after pericardial window surgery: impact of operative technique Sarah E. Langdon, Kristen Seery and Alexander Kulik* Abstract Background: The optimal window procedure for drainage of a large pericardial effusion has yet to be established. The purpose of this study was to compare the outcomes associated with the subxiphoid and thoracotomy pericardial window techniques, with a focus on perioperative pain and effusion recurrence rates. Methods: A retrospective single-center observational study of all pericardial window operations was performed, with the incision based on surgeon preference. Perioperative data was recorded including time to extubation, narcotic requirements, and the development of a recurrent pericardial effusion. Results: From 2002 to 2015, 179 patients with a large pericardial effusion underwent either a subxiphoid (n =127)orleft anterior mini-thoracotomy (n = 52) pericardial window procedure. Patients (mean age 73.2 years, 56 % female) had a high incidence of previous malignancy (49 %), chronic anticoagulation (34 %), recent infection (26 %), or renal failure (18 %). Cardiac tamponade was present in 50 %, and 12 % had undergone previous pericardiocentesis. Comparing the two techniques, there was no difference in the amount of fluid drained or in the perioperative mortality rate. Postoperatively, patients who had the subxiphoid approach required less time before extubation (P = 0.002) and needed less narcotics within 48 h after surgery (P = 0.0001) compared to thoracotomy patients. However, patients treated with the subxiphoid technique more often developed recurrent moderate or large pericardial effusions (P = 0.02), and there was a trend towards more repeat operations needed (P =0.15).
    [Show full text]
  • Abouzeid M, Wyber R, La Vincente S, Sliwa K, Zuhlke L, Mayosi B, Et Al
    Professor Bongani Mayosi: Bibliography 2019 Abouzeid M, Wyber R, La Vincente S, Sliwa K, Zuhlke L, Mayosi B, et al. Time to tackle rheumatic heart disease: Data needed to drive global policy dialogues. Glob Public Health. 2019;14(3):456–468. doi: 10.1080/17441692.2018.1515970. Full text not freely available. Rheumatic heart disease (RHD) is an avoidable disease of poverty that persists predominantly in low resource settings and among Indigenous and other high-risk populations in some high-income nations. Following a period of relative global policy inertia on RHD, recent years have seen a resurgence of research, policy and civil society activity to tackle RHD; this has culminated in growing momentum at the highest levels of global health diplomacy to definitively address this disease of disadvantage. RHD is inextricably entangled with the global development agenda, and effective RHD action requires concerted efforts both within and beyond the health policy sphere. This report provides an update on the contemporary global and regional policy landscapes relevant to RHD, and highlights the fundamental importance of good data to inform these policy dialogues, monitor systems responses and ensure that no one is left behind. Chasseuil E, McGrath JA, Seo A, Balguerie X, Bodak N, Chasseuil H, et al. Dermatological manifestations of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis (POIKTMP): A case series of 28 patients. Br J of Dermatol. 2019. doi: 10.1111/bjd.17996. Full text not freely available. Hereditary Fibrosing Poikiloderma with Tendon Contractures, Myopathy and Pulmonary Fibrosis (POIKTMP [MIM 615704]) is a recently described autosomal dominant disorder due to missense mutations in the FAM111B gene.
    [Show full text]
  • Evaluation of Thoracoscopic Pericardial Window Size and Execution Time in Dogs: Comparison of Two Surgical Approaches
    animals Article Evaluation of Thoracoscopic Pericardial Window Size and Execution Time in Dogs: Comparison of Two Surgical Approaches Francesco Macrì 1, Vito Angileri 1, Claudia Giannetto 1 , Lorenzo Scaletta 2, Piero Miele 2, Loris Pazzaglia 3 and Simona Di Pietro 1,* 1 Department of Veterinary Sciences, University of Messina, Viale Palatucci, 98168 Messina, Italy; [email protected] (F.M.); [email protected] (V.A.); [email protected] (C.G.) 2 Veterinaria Enterprise Stp S.R.L., Via Galvani 33d, 00153 Rome, Italy; [email protected] (L.S.); [email protected] (P.M.) 3 Clinica Veterinaria Galilei, Via B. Franklin 22, 59100 Prato, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-090-6766758 Simple Summary: This canine prospective study was performed to statistically compare the surgery time and achieved windows size of two different thoracoscopic pericardiectomy techniques in dogs affected by pericardial effusion, using transdiaphragmatic paraxyphoid and monolateral intercostal approaches. The paraxifoid and the monolateral intercostal approaches showed a mean surgical time of 55 ± 20.08 (SD) minutes and 13.94 ± 4.61 (SD) minutes, and a mean pericardial window diameter of 4.23 ± 0.80 (SD) cm and 3.31 ± 0.43 (SD) cm, respectively. A significant correlation was observed between the dogs’ bodyweight and window size (r = 0.48; p = 0.04) for both surgical approaches, and between the dogs’ bodyweight and surgical time (r = 0.72; p = 0.0016) for monolateral intercostal Citation: Macrì, F.; Angileri, V.; approach. Our results provided useful information to help surgeons make the definitive choice of the Giannetto, C.; Scaletta, L.; Miele, P.; surgical technique to treat the pericardial effusion.
    [Show full text]